As artificial intelligence (AI) becomes increasingly integrated into the healthcare sector, the year 2026 is poised to be marked by both advancements and resistance. “Well-designed and well-implemented AI scripts will pull the industry forward, while some stakeholders push back against the technology for a variety of reasons,” said Dr. Heather Bassett, Chief Medical Officer of Xsolis. This dynamic interplay will significantly impact payers, providers, and patients alike.
The expansion of AI in regulatory compliance is one area expected to see notable growth. Hospitals and health systems face ongoing challenges in navigating varying state and federal regulations concerning patient consent and data use. In light of these complexities, some providers are opting to apply AI solely to low-risk administrative tasks, while others are venturing into higher-risk, patient-facing applications. As 2026 unfolds, smaller or rural hospitals will likely start integrating AI compliance solutions into their electronic medical record (EMR) systems, paving the way for broader adoption.
Moreover, there is potential for the federal government to reassess the regulatory powers afforded to states concerning AI in healthcare, further emphasizing the need for effective digital compliance solutions capable of adapting to rapid changes.
In clinical settings, while platforms like OpenEvidence show promise in enhancing clinical decision-making and diagnostics, the actual implementation of these toolsets remains varied. A gap persists between the potential benefits of AI and the practical results, often hampered by errors that arise from inadequate vendor safeguards. As hospitals sift through the multitude of available AI tools in 2026, frustrations may mount as they distinguish effective solutions from ineffective ones. Some clinicians may also resist AI adoption out of fear of job displacement, although many healthcare roles are currently understaffed, with AI primarily being introduced to assist overburdened units.
Change management will be crucial in 2026, as healthcare administrators must address both technological advancements and the human element of the workforce. Convincing staff to embrace AI will be just as important as the technology’s implementation.
On the patient side, the experience with AI tools in personal life is expected to ease resistance to such technologies within healthcare settings. Younger patients, particularly those in pediatrics, are likely to be more receptive to AI than older generations. In contrast, geriatric medicine may see more hesitancy due to older patients’ limited experience with technology. Practices will need to tailor their AI rollouts according to demographic factors and actively engage patients in testing new tools to gather valuable feedback.
The introduction of the CMS “Final Rule” in 2026 will also have significant implications for prior authorization processes within Medicare Advantage, Medicaid, CHIP, and certain exchange plans. Under the new regulations, payers must respond to non-urgent prior authorization requests within seven calendar days and to urgent requests within 72 hours. This development underscores the importance of integrating AI tools for efficiency in prior authorization, as companies that have already optimized these processes will have a competitive edge come January 1.
Additionally, CMS will initiate a pilot program on wasteful and inappropriate service reduction (WISeR) in six states, requiring prior authorization for selected outpatient services seen as susceptible to overuse or fraud. Technology and AI-assisted reviews will be allowed, though the final decisions will remain with clinicians.
Collaborative Efforts Toward Best Practices
In October, stakeholders from government, healthcare, academia, and AI sectors convened at the annual “CHAI on the Hill” conference to establish best practices for regulating AI in healthcare. This collaborative approach emphasizes the importance of shared solutions and mitigating pain points across the industry. The summit follows the release of a joint eight-page document from CHAI and the Joint Commission outlining responsible AI use in healthcare, providing a framework for the industry moving forward.
As healthcare transitions from high-level discussions about AI to practical implementation, the coming years will necessitate a unified approach among stakeholders. The ongoing development of regulatory compliance, the integration of AI tools in clinical settings, and efforts to gain patient acceptance will all play pivotal roles in shaping the future landscape of healthcare. The stakes are high, as technological advancements hold the potential to revolutionize patient care and operational efficiency across the sector.
See also
AI Compliance Convergence: 91% of Offboarded Employees Retain Access to Sensitive Data
UN Secretary-General Recommends Maria Ressa for AI Scientific Panel with 40 Experts
DOT Plans to Use Google Gemini for 90% of Federal Rulemaking, Ignoring Legal Risks
FTC Signals Reduced Regulation on AI, Citing Deregulatory Shift Under Trump Administration
FINRA Executive Reveals AI Compliance Strategies for 2026 at Compliance Week Event
